Is TB4-Sulfoxide FDA-approved?

No. TB4-Sulfoxide isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.

Checked 1 Nov 2026. The sources are below.

TB4-Sulfoxide

Also: thymosin beta-4 sulfoxide, Tβ4-SO

Status label in the Peptimes Library
Not FDA-Approved
Routes in Peptimes
SubcutaneousIntramuscularOralSublingualNasalTopicalOther
Updated
1 Nov 2026

US regulatory status

  • FDA status

    Not FDA-Approved. Drugs@FDA lists no application with thymosin beta-4 or thymosin beta-4 sulfoxide as an active ingredient.

    Source: Drugs@FDA, checked 1 Nov 2026

What studies have looked at

Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.

  • In animals or the lab

    In lab tests, thymosin beta-4 sulfoxide inhibited neutrophil chemotaxis. In mice it strongly inhibited inflammatory paw swelling, while the non-oxidized form did not.

    Source: PMID 10581087, checked 1 Nov 2026

  • In animals or the lab

    In wounded zebrafish it triggered the clearing of inflammatory macrophages from the injury, an effect the authors also saw in mice after heart injury. In cultures of human immune cells it lowered interferon-γ.

    Source: PMID 23820300, checked 1 Nov 2026

How to track it in Peptimes

Add TB4-Sulfoxide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”. It is a separate Library entry from TB-500.

  • Routes: the app lets you record whichever route you used; none is established. Its routes are subcutaneous, intramuscular, oral, sublingual, nasal, topical and Other.
  • Logging: the amount you took, the route and how you feel.
  • Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell TB4-Sulfoxide or any other compound.

More sources

  • FDA, Global Substance Registration System, Thymosin beta-4, checked 1 Nov 2026: the sequence of the unoxidized peptide. The registry has no separate record for the sulfoxide.
  • NIH, ClinicalTrials.gov, search for thymosin beta-4 sulfoxide, checked 1 Nov 2026: no registered study.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing